These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 17936803

  • 1. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW.
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 3. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 4. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [Abstract] [Full Text] [Related]

  • 5. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
    Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, Bostwick DG.
    J Urol; 1998 May; 159(5):1497-503. PubMed ID: 9554341
    [Abstract] [Full Text] [Related]

  • 6. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 7. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 8. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F, Anderson H, Månsson W.
    J Urol; 2005 Nov 20; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [Abstract] [Full Text] [Related]

  • 9. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun 20; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

  • 10. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ, Wasco MJ, Wang R, Daignault S, Lee CT, Shah RB.
    J Urol; 2009 Jul 20; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun 20; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 12. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A.
    J Urol; 2008 Nov 20; 180(5):1923-7. PubMed ID: 18801525
    [Abstract] [Full Text] [Related]

  • 13. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.
    BJU Int; 2012 Feb 20; 109(4):564-9. PubMed ID: 21810161
    [Abstract] [Full Text] [Related]

  • 14. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA.
    J Urol; 2012 Aug 20; 188(2):405-9. PubMed ID: 22704101
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 20; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 20; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 17. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar 20; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 18. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP.
    J Urol; 2009 Jul 20; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar 20; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 20. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI.
    J Urol; 2005 Nov 20; 174(5):1976-80. PubMed ID: 16217372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.